1Birnie, D, Williams, K, Guo, A, Mielniczuk, L, Davis, D, Lemery, R, Green, M, Gollob, M, Tang, A. Reasons for escalating pacemaker implants. Am J Cardiol 2006; 98: 93–97.
2James, TN. Normal and abnormal consequences of apoptosis in the human heart. From postnatal morphogenesis to paroxysmal arrhythmias. Circulation 1994; 90: 556–73.
3Da Costa, D, Brady, WJ, Edhouse, J. Bradycardias and atrioventricular conduction block. BMJ 2002; 324: 535–38.
4Kojic, EM, Hardarson, T, Sigfusson, N, Sigvaldason, H. The prevalence and prognosis of third-degree atrioventricular conduction block: the Reykjavik Study. J Internal Med 1999; 246: 81–86.
5Shaw, DB, Kekwick, CA. Potential candidates for pacemakers. Survey of heart block and sinoatrial disorder (sick sinus syndrome). Br Heart J 1978; 40: 99–105.
6Brignole, M. Sick sinus syndrome. Clin Geriatr Med 2002; 18: 211–27.
7Shiraishi, I, Takamatsu, T, Minamikawa, T, Onouchi, Z, Fujita, S. Quantitative histological analysis of the human sinoatrial node during growth and aging. Circulation 1992; 85: 2176–84.
8Bharati, S, Lev, M. The pathologic changes in the conduction system beyond the age of ninety. Am Heart J 1992; 124: 486–96.
9Rajala, S, Kaltula, K, Haavisyo, M, Mattila, K. Prevalence of ECG findings in very old people. Eur Heart J 1984; 5: 168–74.
10Kelley, GP, Stellingworth, MA, Broyles, S, Glancy, DL. Electrocardiographic findings in 888 patients >=90 years of age. Am J Cardiol 2006; 98: 1512–14.
11Lakkireddy, DR, Clark, RA, Mohiuddin, SM. Electrocardiographic findings in patients >100 years of age without clinical evidence of cardiac disease. Am J Cardiol 2003; 92: 1249–51.
12Miller, WL, Hodge, DO, Hammill, SC. Association of uncomplicated electrocardiographic conduction blocks with subsequent cardiac morbidity in a community-based population (Olmsted County, Minnesota). Am J Cardiol 2008; 101: 102–6.
13Vardas, PE, Auricchio, A, Blanc, JJ, Daubert, JC, Drexler, H, Ector, H, Gasparini, M, Linde, C, Morgado, FB, Oto, A, Sutton, R, Trusz-Gluza, M; European Society of Cardiology; European Heart Rhythm Association. Guidelines for cardiac pacing and cardiac resynchronization therapy. The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Europace 2007; 9: 959–98.
14McAnulty, J, Rahimtoola, S, Murphy, E. Natural history of ‘high risk’ bundle branch block: final report of a prospective study. New Engl J Med 1982; 307: 137–43.
15Englund, A. Electrophysiological studies in patients with bifascicular block. Thesis, 1995. Karolinska Institute, Stockholm.
16Ector, H, Vardas, P. Current use of pacemakers, implantable cardioverter defibrillators, and resynchronization devices: data from the registry of the European Heart Rhythm Association. Eur Heart J Suppl 2007; 9 (suppl I): I44–I9.
18Thomas, N. A model patient. BMJ 2007; 334: 193.
19Cunnington, MS, Plummer, CJ, McComb, JM. Delays and adverse clinical outcomes associated with unrecognized pacing indications. QJM 2009; 102: 485–90.
20Cunnington, MS, Plummer, CJ, McComb, JM. A survey of investigations performed prior to permanent pacemaker implantation. Age Ageing 2010; 39: 135–39.
21McComb, JM, Plummer, CJ. Lack of knowledge of pacemaker indications at the front line. Heart 2007; 93 (suppl 1): A46.
22Epstein, AE, DiMarco, JP, Ellenbogen, KA, Estes, NA 3rd, Freedman, RA, Gettes, LS, Gillinov, AM, Gregoratos, G, Hammill, SC, Hayes, DL, Hlatky, MA, Newby, LK, Page, RL, Schoenfeld, MH, Silka, MJ, Stevenson, LW, Sweeney, MO, Smith, SC Jr, Jacobs, AK, Adams, CD, Anderson, JL, Buller, CE, Creager, MA, Ettinger, SM, Faxon, DP, Halperin, JL, Hiratzka, LF, Hunt, SA, Krumholz, HM, Kushner, FG, Lytle, BW, Nishimura, RA, Ornato, JP, Page, RL, Riegel, B, Tarkington, LG, Yancy, CW; American College of Cardiology /American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices); American Association for Thoracic Surgery; Society of Thoracic Surgeons. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol 2008; 51: e1–62.
23Siddons, H. Deaths in long-term paced patients. Br Heart J 1974; 36: 1201–9.
24Ginks, W, Leatham, A, Siddons, H. Prognosis of patients paced for chronic atrioventricular block. Br Heart J 1979; 41: 633–36.
25Dhingra, RC, Denes, P, Wu, D, Chuquimia, R, Rosen, KM. The significance of second degree atrioventricular block and bundle branch block: observations regarding site and type of block. Circulation 1974; 49: 638–46.
26Shaw, DB, Kekwick, CA, Veale, D, Gowers, J, Whistance, T. Survival in second degree atrioventricular block. Br Heart J 1985; 53: 587–93.
27Shaw, DB, Gowers, JI, Kekwick, CA, New, KHJ, Whistance, AWT. Is Mobitz type I atrioventricular block benign in adults? Heart 2004; 90: 169–74.
28Barold, SS. Indications for permanent cardiac pacing in first-degree AV block: class I, II, or III? Pacing Clin Electrophysiol 1996; 19: 747–51.
29Tabrizi, F, Rosenqvist, M, Bergfeldt, L, Englund, A. Time relation between a syncopal event and documentation of atrioventricular block in patients with bifascicular block: clinical implications. Cardiology 2007; 108: 138–43.
30Kennebäck, G, Tabrizi, F, Lindell, P, Nordlander, R. High-degree atrioventricular block during anti-arrhythmic drug treatment: use of a pacemaker with a bradycardia-detection algorithm to study the time course after drug withdrawal. Europace 2007; 9: 186–91.
31Cunnington, MS, Plummer, CJ, McDiarmid, AK, McComb, JM. The patient journey from symptom onset to pacemaker implantation. QJM 2008; 101: 955–60.
32Viskin, S. Long QT syndromes and torsade de pointes. Lancet 1999; 354: 1625–33.
33Kawasaki, R, Machado, C, Reinoehl, J, Fromm, B, Baga, JJ, Steinman, RT, Lehmann, MH. Increased propensity of women to develop torsades de pointes during complete heart block. J Cardiovasc Electrophysiol 1995; 6: 1032–38.
34Shaw, DB, Holman, RR, Gowers, JI. Survival in sinoatrial disorder (sick-sinus syndrome). BMJ 1980; 280: 139–41.
35Thomas, H, Plummer, C, Turley, A, McComb, J. Indications for permanent pacing: the three second pause is an arbitrary and inappropriate discriminator. Unpublished observations, 2010.
36Zeltser, D, Justo, D, Halkin, A, Rosso, R, Ish-Shalom, M, Hochenberg, M, Viskin, S. Drug-induced atrioventricular block: prognosis after discontinuation of the culprit drug. J Am Coll Cardiol 2004; 44: 105–8.
37Essebag, V, Reynolds, MR, Hadjis, T, Lemery, R, Olshansky, B, Buxton, AE, Josephson, ME, Zimetbaum, P. Sex differences in the relationship between amiodarone use and the need for permanent pacing in patients with atrial fibrillation. Arch Intern Med 2007; 167: 1648–53.
38Essebag, V, Hadjis, TOM, Platt, RW, Abrahamowicz, M, Pilote, L. Effect of amiodarone dose on the risk of permanent pacemaker insertion. Pacing Clin Electrophysiol 2004; 27: 1519–25.
39Essebag, V, Hadjis, T, Platt, RW, Pilote, L. Amiodarone and the risk of bradyarrhythmia requiring permanent pacemaker in elderly patients with atrial fibrillation and prior myocardial infarction. J Am Coll Cardiol 2003; 41: 249–54.
40Hernandez, RK, Farwell, W, Cantor, MD, Lawler, EV. Cholinesterase inhibitors and incidence of bradycardia in patients with dementia in the veterans affairs new England healthcare system. J Am Geriatr Soc 2009; 57: 1997–2003.
41Gill, SS, Anderson, GM, Fischer, HD, Bell, CM, Li, P, Normand, SL, Rochon, PA. Syncope and its consequences in patients with dementia receiving cholinesterase inhibitors: a population-based cohort study. Arch Intern Med 2009; 169: 867–73.
42Sutton, R, Petersen, MEV. The clinical spectrum of neurocardiogenic syncope. J Cardiovasc Electrophysiol 1995; 6: 569–76.
43Grubb, BP. Neurocardiogenic syncope and related disorders of orthostatic intolerance. Circulation 2005; 111: 2997–3006.
44Tan, MP, Parry, SW. Vasovagal syncope in the older patient. J Am Coll Cardiol 2008; 51: 599–606.
45Ammirati, F, Colivicchi, F, Santini, M. Diagnosing syncope in the clinical practice. Implementation of a simplified diagnostic algorithm in a multicentre prospective trial-the OESIL 2 study (Osservatorio Epidemiologico della Sincope nel Lazio). Eur Heart J 2000; 21: 935–40.
46Blanc, J, L'Her, C, Touiza, A. Prospective evaluation and outcome of patients admitted for syncope over 1 year period. Eur Heart J 2002; 23: 815–20.
47Disertori, M, Brignole, M, Menozzi, C et al. . Management of syncope referred for emergency to general hospitals. Europace 2003; 5: 283–91.
48Sud, S, Massel, D, Klein, GJ, Leong-Sit, P, Yee, R, Skanes, AC, Gula, LJ, Krahn, AD. The expectation effect and cardiac pacing for refractory vasovagal syncope. Am J Med 2007; 120: 54–62.
49Sutton, R, Brignole, M, Menozzi, C, Raviele, A, Alboni, P, Giani, P, Moya, A. Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope: pacemaker versus no therapy: a multicenter randomized study. Circulation 2000; 102: 294–99.
50Connolly, SJ, Sheldon, R, Roberts, RS, Gent, M, on Behalf of the Vasovagal Pacemaker Study Investigators. The North American vasovagal pacemaker study (VPS): A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. J Am Coll Cardiol 1999; 33: 16–20.
51Connolly, SJ, Sheldon, R, Thorpe, KE, Roberts, RS, Ellenbogen, KA, Wilkoff, BL, Morillo, C, Gent, M; VPS II Investigators. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope. JAMA 2003; 289: 2224–29.
52Raviele, A, Giada, F, Menozzi, C, Speca, G, Orazi, S, Gasparini, G, Sutton, R, Brignole, M; Vasovagal Syncope and Pacing Trial Investigators. A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The vasovagal syncope and pacing trial (SYNPACE). Eur Heart J 2004; 25: 1741–48.
53Dey, AB, Stout, NR, Kenny, RA. Cardiovascular syncope is the most common cause of drop attacks in the elderly. Pacing Clin Electrophysiol 1997; 20: 818–19.
54Richardson, DA, Bexton, RS, Shaw, FE, Kenny, RA. Prevalence of cardioinhibitory carotid sinus hypersensitivity in patients 50 years or over presenting to the Accident and Emergency Department with ‘unexplained’ or ‘recurrent’ falls. Pacing Clin Electrophysiol 1997; 20: 820–23.
55Parry, SW, Steen, IN, Baptist, M, Kenny, RA. Amnesia for loss of consciousness in carotid sinus syndrome: implications for presentation with falls. J Am Coll Cardiol 2005; 45: 1840–43.
56Brignole, M, Menozzi, C, Lolli, G, Bottoni, N, Gaggioli, G. Long-term outcome of paced and non-paced patients with severe carotid sinus syndrome. Am J Cardiol 1992; 69: 1039–43.
57Kenny, RA, Richardson, DA, Steen, N, Bexton, RS, Shaw, FE, Bond, J. Carotid sinus syndrome: a modifiable risk factor for non-accidental falls in older adults (SAFE PACE). J Am Coll Cardiol 2001; 38: 1491–96.
58Parry, SW, Steen, N, Bexton, RS, Tynan, M, Kenny, RA. Pacing in elderly recurrent fallers with carotid sinus hypersensitivity: a randomised, double-blind, placebo controlled crossover trial. Heart 2009; 95: 405–9.
59Tan, MP, Newton, JL, Reeve, P, Murray, A, Chadwick, TJ, Parry, SW. Results of carotid sinus massage in a tertiary referral unit – is carotid sinus syndrome still relevant? Age Ageing 2009; 38: 680–86.
60McAlister, FA, Ezekowitz, J, Hooton, N, Vandermeer, B, Spooner, C, Dryden, DM, Page, RL, Hlatky, MA, Rowe, BH. Cardiac resynchronization therapy for patients with left ventricular systolic sysfunction. JAMA 2007; 297: 2502–14.
61Yao, G, Freemantle, N, Calvert, MJ, Bryan, S, Daubert, J-C, Cleland, JGF. The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator. Eur Heart J 2007; 28: 42–51.
62Schmidt, B, Brunner, M, Olschewski, M, Hummel, C, Faber, TS, Grom, A, Giesler, U, Bode, C, Zehender, M. Pacemaker therapy in very elderly patients: long-term survival and prognostic parameters. Am Heart J 2003; 146: 908–13.
63Birnie, DH, Sambell, C, Johansen, H, Williams, K, Lemery, R, Green, MS, Gollob, MH, Lee, DS, Tang, AS. Use of implantable cardioverter defibrillators in Canadian and US survivors of out-of-hospital cardiac arrest. CMAJ 2007; 177: 41–46.
64Toff, WD, Camm, AJ, Skehan, JD. Single-chamber versus dual-chamber pacing for high-grade atrioventricular block. N Engl J Med 2005; 353: 145–55.
65Lamas, GA, Pashos, CL, Normand, S-LT, McNeil, B. Permanent pacemaker selection and subsequent survival in elderly Medicare pacemaker recipients. Circulation 1995; 91: 1063–69.
66Brady, PA, Shen, WK, Neubauer, SA, Hammill, SC, Hodge, DO, Hayes, DL. Pacing mode and long-term survival in elderly patients with congestive heart failure: 1980–1985. J Interv Card Electrophysiol 1997; 1: 193–201.
67Sweeney, MO, Hellkamp, AS, Ellenbogen, KA, Lamas, GA. Reduced ejection fraction, sudden cardiac death, and heart failure death in the mode selection trial (MOST): implications for device selection in elderly patients with sinus node disease. J Cardiovasc Electrophysiol 2008; 19: 1160–66.
68Lamas, GA, Orav, EJ, Stambler, BS, Ellenbogen, KA, Sgarbossa, EB, Huang, SK, Marinchak, RA, Estes, NA 3rd, Mitchell, GF, Lieberman, EH, Mangione, CM, Goldman, L. Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. New Engl J Med 1998; 338: 1097–104.
69Gribbin, GM, Kenny, RA, McCue, P, Toff, WD, Bexton, RS, McComb, JM. Individualised quality of life after pacing. Does mode matter? Europace 2004; 6: 552–60.
70van Hemel, NM, Holwerda, KJ, Slegers, PC, Spierenburg, HA, Timmermans, AA, Meeder, JG, van der Kemp, P, Kelder, JC, Stofmeel, MA; Sensor and Quality of Life (SQL) Investigators. The contribution of rate adaptive pacing with single or dual sensors to health-related quality of life. Europace 2007; 9: 233–38.
71Fleischmann, KE, Orav, EJ, Lamas, GA, Mangione, CM, Schron, E, Lee, KL, Goldman, L. Pacemaker implantation and quality of life in the Mode Selection Trial (MOST). Heart Rhythm 2006; 3: 653–59.
72Gribbin, GM, Gallagher, P, Young, AH, McComb, JM, McCue, P, Toff, WD, Bexton, RS, Bland, JM, Kenny, RA. The effect of pacemaker mode on cognitive function. Heart 2005; 91: 1209–10.
73Castelnuovo, E, Stein, K, Pitt, M, Garside, R, Payne, E. The effectiveness and cost-effectiveness of dual-chamber pacemakers compared with single-chamber pacemakers for bradycardia due to atrioventricular block or sick sinus syndrome: systematic review and economic evaluation. Health Technol Assess 2005; 9: iii, xi–xiii, 1–246.
74Bernstein, AD, Daubert, JC, Fletcher, RD, Hayes, DL, Lüderitz, B, Reynolds, DW, Schoenfeld, MH, Sutton, R. The revised NASPE/BPEG generic code for antibradycardia, adaptive-rate, and multisite pacing. North American Society of Pacing and Electrophysiology/British Pacing and Electrophysiology Group. Pacing Clin Electrophysiol 2002; 25: 260–64.
75Lamas, GA, Orav, EJ, Stambler, BS, Ellenbogen, KA, Sgarbossa, EB, Huang, SK, Marinchak, RA, Estes, NA 3rd, Mitchell, GF, Lieberman, EH, Mangione, CM, Goldman, L. Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. Pacemaker Selection in the Elderly Investigators. N Engl J Med 1998; 338: 1097–104.
76Connolly, SJ, Kerr, CR, Gent, M, Roberts, RS, Yusuf, S, Gillis, AM, Sami, MH, Talajic, M, Tang, AS, Klein, GJ, Lau, C, Newman, DM. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators. N Engl J Med 2000; 342: 1385–91.
77Lamas, GA, Lee, KL, Sweeney, MO, Silverman, R, Leon, A, Yee, R, Marinchak, RA, Flaker, G, Schron, E, Orav, EJ, Hellkamp, AS, Greer, S, McAnulty, J, Ellenbogen, K, Ehlert, F, Freedman, RA, Estes, NA 3rd, Greenspon, A, Goldman, L; Mode Selection Trial in Sinus-Node Dysfunction. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med 2002; 346: 1854–62.
78Wilkoff, BL, Cook, JR, Epstein, AE, Greene, HL, Hallstrom, AP, Hsia, H, Kutalek, SP, Sharma, A; Dual Chamber and VVI Implantable Defibrillator Trial Investigators. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 2002; 288: 3115–23.
79Sweeney, MO, Bank, AJ, Nsah, E, Koullick, M, Zeng, QC, Hettrick, D, Sheldon, T, Lamas, GA; Search AV Extension and Managed Ventricular Pacing for Promoting Atrioventricular Conduction (SAVE PACe) Trial. Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node eisease. New Engl J Med 2007; 357: 1000–8.
80Dretzke, J, Toff, WD, Lip, GY, Raftery, J, Fry-Smith, A, Taylor, R. Dual chamber versus single chamber ventricular pacemakers for sick sinus syndrome and atrioventricular block. Cochrane Database Syst Rev 2004; (2): CD003710.
81Winner, S, Boon, N. Clinical problems with temporary pacemakers prior to permanent pacing. J R Coll Physicians Lond 1979; 23:161–63.
82Falk, RH, Zoll, PM, Zoll, RH. Safety and efficacy of non-invasive cardiac pacing. New Engl J Med 1983; 309: 1166–68.
83Zoll, P, Zoll, R, Falk, R, Clinton, J, Eitel, D, Antman, E. External non-invasive temporary cardiac pacing: clinical trials. Circulation 1985; 71: 937–44.
84Betts, TR. Regional survey of temporary transvenous pacing procedures and complications. Postgrad Med J 2003; 79: 463–65.
85Klug, D, Balde, M, Pavin, D, Hidden-Lucet, F, Clementy, J, Sadoul, N, Rey, JL, Lande, G, Lazarus, A, Victor, J, Barnay, C, Grandbastien, B, Kacet, S; PEOPLE Study Group. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation 2007; 116: 1349–55.
86Murphy, JJ. Current practice and complications of temporary transvenous cardiac pacing. BMJ 1996; 312: 1134.
87Osman, F, Krishnamoorthy, S, Nadir, A, Mullin, P, Morley-Davies, A, Creamer, J. Safety and cost-effectiveness of same day permanent pacemaker implantation. Am J Cardiol 2010; 106: 383–85.
88Ellenbogen, KA, Hellkamp, AS, Wilkoff, BL, Camunãs, JL, Love, JC, Hadjis, TA, Lee, KL, Lamas, GA. Complications arising after implantation of DDD pacemakers: the MOST experience. Am J Cardiol 2003; 92: 740–41.
89Healey, J, Armaganijan, L, Nair, G, Morillo, C, Divakaramenon, S, Connolly, S. Risk of complications among elderly recipients of permanent pacemakers. Canadian J Cardiol 2010; 26 (suppl): 424.
90Andersen, HR, Nielsen, JC, Thomsen, PE, Thuesen, L, Mortensen, PT, Vesterlund, T, Pedersen, AK. Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet 1997; 350: 1210–16.
91Wilkoff, BL, Auricchio, A, Brugada, J, Cowie, M, Ellenbogen, KA, Gillis, AM, Hayes, DL, Howlett, JG, Kautzner, J, Love, CJ, Morgan, JM, Priori, SG, Reynolds, DW, Schoenfeld, MH, Vardas, PE; Heart Rhythm Society (HRS); European Heart Rhythm Association (EHRA); American College of Cardiology (ACC); American Heart Association (AHA); European Society of Cardiology (ESC); Heart Failure Association of ESC (HFA); Heart Failure Society of America (HFSA). HRS/EHRA Expert Consensus on the Monitoring of Cardiovascular Implantable Electronic Devices (CIEDs): Description of Techniques, Indications, Personnel, Frequency and Ethical Considerations: Developed in partnership with the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA); and in collaboration with the American College of Cardiology (ACC), the American Heart Association (AHA), the European Society of Cardiology (ESC), the Heart Failure Association of ESC (HFA), and the Heart Failure Society of America (HFSA). Endorsed by the Heart Rhythm Society, the European Heart Rhythm Association (a registered branch of the ESC), the American College of Cardiology, the American Heart Association. Europace 2008; 10: 707–25.
92Huagui, L, Dhanunjaya, L, Hema, K, Karen, R, Tom, H. Pacemaker utilization during permanent atrial fibrillation in patients who received pacemaker implantation for sinus node dysfunction. Am J Cardiol 2005; 96: 942–45.
93Sgarbossa, EB, Pinski, SL, Jaeger, FJ, Trohman, RG, Maloney, JD. Incidence and predictors of syncope in paced patients with sick sinus syndrome. Pacing Clinl Electrophysiol 1992; 15: 2055–60.
94Pavlovic, SU, Kocovic, D, Djordjevic, M, Belkic, K, Kostic, D, Velimirovic, D. The etiology of syncope in pacemaker patients. Pacing Clin Electrophysiol 1991; 14: 2086–91.
95Brignole, M, Menozzi, C, Lolli, G, Oddone, D, Gianfranchi, L, Bertulla, A. Pacing for carotid sinus syndrome and sick sinus syndrome. Pacing Clin Electrophysiol 1990; 13: 2071–75.
96Skanes, AC, Krahn, AD, Yee, R, Klein, GJ, Connolly, SJ, Kerr, CR, Gent, M, Thorpe, KE, Roberts, RS; Canadian Trial of Physiologic Pacing. Progression to chronic atrial fibrillation after pacing: the Canadian Trial of Physiologic Pacing. J Am Coll Cardiol 2001; 38: 167–72.
97Toff, WD, Camm, AJ, Skehan, JD. Single-chamber versus dual-chamber pacing for high-grade atrioventricular block. New Engl J Med 2005; 353: 145–55.
98Glotzer, TV, Hellkamp, AS, Zimmerman, J, Sweeney, MO, Yee, R, Marinchak, R, Cook, J, Paraschos, A, Love, J, Radoslovich, G, Lee, KL, Lamas, GA; MOST Investigators. Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: Report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST). Circulation 2003; 107: 1614–19.
99Gage, BF, Waterman, AD, Shannon, W, Boechler, M, Rich, MW, Radford, MJ. Validation of clinical classification schemes for predicting stroke. JAMA 2001; 285: 2864–70.
100Lip, GYH, Nieuwlaat, R, Pisters, R, Lane, DA, Crijns, HJGM. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach. Chest 2010; 137: 263–72.
101Lip, GYH, Frison, L, Halperin, JL, Lane, D. Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score. J Am Coll Cardiol 2011; 57: 173–80.
102Mueller, PS, Hook, CC, Hayes, DL. Ethical analysis of withdrawal of pacemaker orimplantable cardioverter-defibrillator support at the end of life. Mayo Clinic Proc 2003; 78: 959–63.
103Lampert, R, Hayes, DL, Annas, GJ, Farley, MA, Goldstein, NE, Hamilton, RM, Kay, GN, Kramer, DB, Mueller, PS, Padeletti, L, Pozuelo, L, Schoenfeld, MH, Vardas, PE, Wiegand, DL, Zellner, R; American College of Cardiology; American Geriatrics Society; American Academy of Hospice and Palliative Medicine, American Heart Association; European Heart Rhythm Association; Hospice and Palliative Nurses Association. HRS Expert Consensus Statement on the Management of Cardiovascular Implantable Electronic Devices (CIEDs) in patients nearing end of life or requesting withdrawal of therapy: This document was developed in collaboration and endorsed by the American College of Cardiology (ACC), the American Geriatrics Society (AGS), the American Academy of Hospice and Palliative Medicine (AAHPM); the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), and the Hospice and Palliative Nurses Association (HPNA). Heart Rhythm: the official journal of the Heart Rhythm Society 2010; 7: 1008–26.
104Gale, C, Mulley, G. Pacemaker explosions in crematoria: problems and possible solutions. J R Soc Med 2002; 95: 353–55.
105Ghosh, D, James, M, Palmer, R. ICD electrical injury on removal of implantable defibrillator after death. Heart 1997; 77: 484–85.